Regeneron Pharmaceuticals REGN
NASDAQ REGN
$904.35 +1.45 (+0.16%)
At close: Nov 6, 2026 · 4:00 PM EST

Regeneron Pharmaceuticals (REGN) Cash & Current Investments (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Cash & Current Investments came in at $9.3 billion for Q3 2026, up 10.2% from $8.44 billion a year earlier and up 16.3% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Regeneron Pharmaceuticals' Cash & Current Investments was $8.61 billion, down 4.5% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $9.01 billion in FY2024 (-16.9%), $10.84 billion in FY2023 (+40.1%), $7.74 billion in FY2022 (+36.0%) and $5.69 billion in FY2021 (+58.8%).
  • The Q3 2026 figure represents the highest quarterly Cash & Current Investments since Q3 2024.
  • Year-over-year, Cash & Current Investments has increased for three consecutive quarters, with an average decline of 7.2% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2022 (growth of 101.2%), and the weakest in Q2 2025 (a decline of 23.8%).
  • Business Quant data shows REGN's Cash & Current Investments at $7.99 billion (Q2 2026), $8.75 billion (Q1 2026) and $8.61 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.23 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 10.77 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - 505.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 7.94 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 14.27 Bn
10 Regeneron Pharmaceuticals 92.03 Bn 57.37 Bn 4.54 Bn 9.30 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.30 Bn
Jun 30, 2026 7.99 Bn
Mar 31, 2026 8.75 Bn
Dec 31, 2025 8.61 Bn
Sep 30, 2025 8.44 Bn
Jun 30, 2025 7.47 Bn
Mar 31, 2025 8.35 Bn
Dec 31, 2024 9.01 Bn
Sep 30, 2024 9.80 Bn
Jun 30, 2024 9.81 Bn
Mar 31, 2024 10.52 Bn
Dec 31, 2023 10.84 Bn
Sep 30, 2023 9.91 Bn
Jun 30, 2023 8.93 Bn
Mar 31, 2023 8.96 Bn
Dec 31, 2022 7.74 Bn
Sep 30, 2022 7.02 Bn
Jun 30, 2022 7.57 Bn
Mar 31, 2022 7.05 Bn
Dec 31, 2021 5.69 Bn
API Access

Regeneron Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=REGN&period=max&api_key=YOUR_API_KEY